This AI Robot is built exclusively for day traders who embrace the art of manual trading and prioritize independent signal selection. With a track record of consistent trading predictions, it empowers traders to make informed choices that align with their individual preferences.
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)
This specialized robot centers its focus on identifying potent short-term price impulses, aiming for swift and efficient profit extraction. With an average trade duration of one day, it enables effective capital utilization and prevents prolonged entanglements in trades.
The algorithm operates on a distinct, intricate approach that identifies potent price impulses across varying market conditions, considering volatility and historical price patterns. Upon pinpointing the situation with the highest probability of sustained price movement, the analysis shifts to the next phase: identifying the ideal entry point utilizing a proprietary set of indicators that evaluate both medium-term and short-term trends.
After opening a trade, two different approaches are used for long and short positions. For long positions, a fixed take profit of 3.25% is established, coupled with a short-term trailing stop. Conversely, short positions adhere to a fixed take profit of 2.5% and a short-term trailing stop.
In our trading endeavors, we opt for the most liquid and actively traded stocks within the dynamic US stock market. This judicious selection streamlines trade execution at desired entry points, alleviating concerns about spreads and liquidity. Additionally, our decision-making is informed by fundamental indicators, steering us clear of shares associated with subpar business quality, and consequently, minimizing exposure to potential risks like bankruptcy or delisting.
Click to view full description and closed trades for free!
HIVE moved above its 50-day moving average on November 27, 2024 date and that indicates a change from a downward trend to an upward trend. In of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for HIVE moved above the 200-day moving average on October 25, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 209 cases where HIVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for HIVE moved out of overbought territory on November 13, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on November 21, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on November 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HIVE broke above its upper Bollinger Band on November 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.722) is normal, around the industry mean (5.702). P/E Ratio (6.725) is within average values for comparable stocks, (34.201). HIVE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.610). HIVE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.367) is also within normal values, averaging (112.495).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock worse than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers